U.S. House of Representatives[...]
Post Committee Resolution 118-33 A Resolution Allocating Funds from the[...]
Nipocalimab pivotal Phase 3 trial demonstrates longest sustained[...]
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at[...]
06/28/2024 | Press release | Distributed by Public on 06/28/2024 08:06
Please select the service you want to use:
Smartlinks | Keppel Infrastructure Trust | Keppel Ltd. | News | Health | Finance | Conglomerates and Diversified | Security Markets | Fixed Income | Security Markets | Company News | Corporate Debt | Chemicals | Financial Services | Investment Funds | Manufacturing | Real Estate | Securities Issuers | Commercial REITs | Singapore Exchange (SGX) | OTC Markets
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact